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Identification, replication and 
characterization of epigenetic 
remodelling in the aging genome:  
a cross population analysis
Shuxia Li1, Lene Christiansen2, Kaare Christensen2, Torben A. Kruse1, Paul Redmond3, 
Riccardo E. Marioni4,5,6, Ian J. Deary3,5 & Qihua Tan  1,2
Aging is a complex biological process regulated by multiple cellular pathways and molecular 
mechanisms including epigenetics. Using genome-wide DNA methylation data measured in a large 
collection of Scottish old individuals, we performed discovery association analysis to identify age-
methylated CpGs and replicated them in two independent Danish cohorts. The double-replicated 
CpGs were characterized by distribution over gene regions and location in relation to CpG islands. 
The replicated CpGs were further characterized by involvement in biological pathways to study their 
functional implications in aging. We identified 67,604 age-associated CpG sites reaching genome-wide 
significance of FWER <0.05, 86% demethylated with increasing age. Double-replication resulted 
in 5,168 CpGs (39% age-methylated and 61% age-demethylated) which were characterized by high 
concentration of age-methylated CpGs at 1stExon and TSS200 and a dominant pattern of age-
demethylated CpGs at other gene regions, and by overwhelming age-related methylation in CpG islands 
and demethylation at shore/shelf and open sea. The differential distribution patterns over gene regions 
for methylated and demethylated CpGs both relate to reduced gene activity during aging. Pathway 
analysis showed that age-dependent methylations were especially involved in cellular signalling 
activities while demethylations particularly linked to functions of the extracellular matrix, all implicated 
in the aging process and age-related disease risk.
Current development in genomic analysis technologies such as the DNA microarrays and next generation 
sequencing (NGS) has enabled in-depth analysis of the epigenome. In the literature, age and aging associated 
epigenetic profiles have been detected by the epigenome-wide association studies (EWAS) using cross-sectional 
and longitudinal designs, respectively1–6. These studies have reported a considerable number of genomic sites dif-
ferentially methylated over different ages, and during aging within the same individuals. Based on the significant 
CpG sites from EWAS, biological pathway analysis revealed important functional pathways concerning cell-cell 
signalling, synaptic transmission and multiple signalling pathways that overlap across studies3, 5. Although these 
were mainly obtained from the DNA methylome of whole blood corrected for cell composition, the identified 
pathways could reflect the generic aging-related epigenetic changes that are not tissue specific5.
Aging is a complex biological process that involves numerous changes at various levels and in different organ 
systems from molecular modification to the functional regulation of systems through multiple biological mecha-
nisms including epigenetics7, 8. As a reflection of this, most of the epigenetic association analyses of human aging 
have reported relatively large numbers of differentially regulated sites4–6. While the reported findings could reflect 
extensive involvement of epigenetic modification during the aging process, careful validation of the findings are 
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especially necessary both for reducing false discovery and for better characterizing the epigenetic changes accom-
panying human aging.
Based on genome-wide DNA methylation measurements from a large collection of blood samples from older 
people, we conducted a EWAS on aging to look for CpG sites differentially methylated with increasing age using 
a double validation scheme of independent samples. The double-replicated CpGs were characterized by grouping 
across genomic regions and by investigating their functional pathways implicated in the dynamic patterns of 
age-related epigenetic modifications.
Results
EWAS and replication analysis. Following the procedure described in Methods section, the EWAS 
on LBC samples identified a total of 67,604 CpGs with FWER < 0.05. Among them, 9,688 CpGs (14%) were 
age-methylated and 57,916 CpGs (86%) were age-demethylated. The results show a predominant pattern of 
demethylation with increasing age in the significant CpGs. Replication analysis of these CpGs in the Danish 
cross-sectional twin samples found 19,768 CpGs showing same direction of change (increase or decrease) over 
age with p < 0.05, a replication rate of 29.2%. Replication using the Danish longitudinal twins resulted in 7,238 
CpGs with same direction of age pattern and p value < 0.05, a replication rate of 10.7%. Interestingly, among the 
CpGs replicated in the Danish longitudinal twin samples, 5,168 overlap with the 19,768 CpGs replicated in the 
cross-sectional samples, an overlapping rate of 70.4%. Among the double-replicated 5,168 CpGs, 2,028 CpGs 
(39%) were age-methylated and 3,140 (61%) were age-demethylated, again exhibiting a prevailing pattern of 
demethylation with age (see Supplementary Table S1). In Fig. 1, we show the replication results by plotting regres-
sion coefficients of the 67,604 significant CpGs from the discovery LBC samples (the horizontal axis) against 
corresponding coefficients from the cross-sectional validation samples (the vertical axis) with replicated CpGs 
marked blue. On top of that, we further display the double replicated CpGs with red colour. The double-replicated 
CpGs tend to be scattered further away from the unreplicated CpGs coloured by light grey suggesting increased 
reliability. In the subsequent analysis, we focused on the 5,168 double-replicated CpGs.
Distribution of age-related CpG sites over gene region. The double-replicated 5,168 CpGs were first 
divided over gene regions separately for CpGs that displayed increased and decreased methylation patterns with 
age. The proportions of CpGs by gene region in the age-methylated or demethylated groups (columns 3 and 6 
in Table 1) were then compared to the corresponding proportions for all CpGs in the whole array (column 2 in 
Table 1) to see if some gene regions were over-represented in each of the two groups. Figure 2a displays the pro-
portion of CpGs by gene region in the groups of increased (red curve) and decreased (blue curve) methylation 
with the dashed curve representing proportion in the overall array. It is clear that the age-dependent DNA meth-
ylation is more frequent at 1stExon (18.44% vs 8.09%) but less frequent in the gene body (27.42% vs 36.09%). In 
contrast, the age-associated demethylation happens more frequently at the region covering −200 to −1500 nt 
upstream of the transcription start site (TSS) (TSS1500) (24.65% vs 17.34%) but less frequently at the region up 
to −200 nt upstream of TSS (TSS200) (5.73% vs 12.87%) and 1stExon (3.63% vs 8.09%). The differential patterns 
are supported by the very high statistical significance in Table 1.
In addition to comparing the relative proportions of CpGs by gene region, we also compared the absolute 
proportions of age-dependent methylation and demethylation in the double-replicated CpGs at each gene 
region (Table 2). Most of the gene regions had more demethylated than methylated CpGs except for TSS200 and 
1stExon. This is easily seen in Fig. 2b where most of the red curve for age-methylated CpGs is inside the blue 
Figure 1. Replication results for the 67,604 significant CpGs identified in the discovery stage. The CpGs 
coloured with blue and red are the 19,768 CpGs replicated by the Danish cross-sectional twin samples. The red 
dots represent specifically the 5,168 CpGs double replicated by both Danish cross-sectional and longitudinal 
samples.
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curve for demethylated CpGs excluding TSS200 and 1stExon. The differential pattern is again extremely signifi-
cant as indicated by p values in Table 2.
Distribution of age-related CpG sites in relation to CpG island (CGI). Similar to the characterization 
by gene region, we next grouped the age-associated CpGs by their relation to CGI. We started with comparing 
the relative proportions of CpGs at their locations to CGI (island, shore, shelf, non-CGI) with the corresponding 
proportions for all CpGs in the whole array (Table 3, Fig. 3a). As shown by Fig. 3a, the age-methylated CpGs are 
predominantly distributed to the island (76.63% vs 30.89%) and rarely to the non-CGI region (6.11% vs 36.38%). 
On the contrary, the age-demethylated CpGs are more frequently distributed over all locations except the island. 
Comparison of the absolute proportions of age-dependent methylation and demethylation in significant CpGs 
at each location is presented in Table 4 and Fig. 3b. The significant CpGs at the island are mostly age-methylated 
(92.39%) while the rest of locations are mainly occupied by age-associated demethylation.
After separately examining the differential methylation patterns by gene region and by relative location to 
CGI, we further divided the 5,168 CpGs by both gene region and CGI location and compared the proportions of 
age-associated methylation and demethylation at each combination to examine the methylation patterns across 
gene regions for a given CGI location or across CGI locations (Table 5). Table 5 shows that increased methylation 
Gene region
Whole 
array Gain χ2 P value Loss χ2 P value
Intergenic 0.25 0.29 21.27 3.99E-06 0.26 2.82 9.33E-02
TSS1500 0.17 0.14 13.93 1.90E-04 0.25 114.38 1.08E-26
TSS200 0.13 0.13 0.22 6.40E-01 0.06 142.40 7.93E-33
5′UTR 0.14 0.14 1.18 2.77E-01 0.12 4.41 3.57E-02
1stExon 0.08 0.18 286.57 2.78E-64 0.04 83.66 5.89E-20
Body 0.36 0.27 66.57 3.38E-16 0.38 5.10 2.39E-02
3′UTR 0.04 0.02 26.65 2.44E-07 0.04 0.28 6.00E-01
Table 1. Proportionality of gene regions for all CpGs of the array and in age-methylated (gain) and 
demethylated (loss) CpGs.
Figure 2. Starplots showing (a) proportionality of gene regions for the age-methylated (red) and demethylation 
(blue) CpGs; and (b) region-specific proportion of age-methylated (red) and demethylated (blue) CpGs in all 
double-replicated CpGs in the gene region.
Gene region Replicated CpGs Gain % Loss % χ2 P value
Intergenic 1405 590 0.42 815 0.58 71.42 2.88E-17
TSS1500 1062 288 0.27 774 0.73 442.98 2.43E-98
TSS200 434 254 0.59 180 0.41 24.56 7.21E-07
5′UTR 674 291 0.43 383 0.57 24.57 7.16E-07
1stExon 488 374 0.77 114 0.23 274.92 9.60E-62
Body 1753 556 0.32 1197 0.68 467.31 1.23E-103
3′UTR 170 36 0.21 134 0.79 110.69 6.90E-26
Table 2. Proportion of age-methylated (gain) and demethylated (loss) CpG in each region.
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Relation to 
CGI
Whole 
array Gain χ2 P value Loss χ2 P value
non-CGI 0.36 0.06 793.97 3.99E-06 0.45 101.92 5.79E-24
N_Shelf 0.05 0.01 79.07 5.99E-19 0.06 7.89 4.97E-03
N_Shore 0.13 0.10 19.05 1.27E-05 0.21 197.75 6.48E-45
Island 0.31 0.77 1963.21 0 0.04 1056.14 1.12E-231
S_Shore 0.10 0.06 36.31 1.68E-09 0.18 221.97 3.36E-50
S_Shelf 0.05 0.01 66.05 4.41E-16 0.05 1.47 2.25E-01
Table 3. Proportionality of locations to CGI for all CpGs of the array and in age-methylated (gain) and 
demethylated (loss) CpGs.
Figure 3. Starplots showing (a) proportionality of locations in relation to CpG island for the age-methylation 
(red) and demethylation (blue) CpGs; and (b) location-specific proportion of age-methylated (red) and 
demethylated (blue) CpGs in all double-replicated CpGs in the location.
Relation to 
CGI Replicated CpGs Gain % Loss % χ2 P value
non-CGI 1536 124 0.08 1412 0.92 2156.73 0
N_Shelf 211 15 0.07 196 0.93 307.11 9.31E-69
N_Shore 869 196 0.23 673 0.77 521.46 2.03E-115
Island 1682 1554 0.92 128 0.08 2414.54 0
S_Shore 695 123 0.18 572 0.82 577.57 1.27E-127
S_Shelf 175 16 0.09 159 0.91 230.45 4.77E-52
Table 4. Proportion of age-methylated (gain) and demethylated (loss) CpG by location to CGI.
Gene region
Non-CGI Shore/Shelf CGI
Gain Loss % P value Gain Loss % P value Gain Loss % P value
Intergenic 423 27 0.94 7.97E-153 118 327 0.27 3.41E-44 49 461 0.10 4.41E-146
TSS1500 221 26 0.89 3.05E-68 57 542 0.10 4.09E-172 10 206 0.05 1.49E-78
TSS200 206 13 0.94 3.41E-75 39 72 0.35 1.74E-05 9 95 0.09 4.53E-32
5′UTR 224 17 0.93 1.43E-78 48 216 0.18 7.22E-48 19 150 0.11 2.09E-45
1stExon 333 4 0.99 7.15E-141 29 51 0.36 8.99E-04 12 59 0.17 1.16E-14
Body 413 51 0.89 3.54E-124 100 630 0.14 9.44E-169 43 516 0.08 2.33E-175
3′UTR 20 9 0.69 8.64E-03 13 52 0.20 2.64E-11 3 73 0.04 4.40E-29
Table 5. Proportion of age-methylated CpGs in double-replicated CpGs by combination of gene region and 
relation to CGI.
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is consistently observed in very high proportion at CGIs in all gene regions and in low proportion (thus high 
proportion of demethylation) at shore/shelf and non-CGI. This is visualized in Fig. 4 where it is shown that the 
proportion of age-methylated CpGs is mainly determined by relative location of the CpG sites to CGI with only 
minor variation across gene regions. Inspired by Fig. 4, we plot the proportion of age-methylated CpGs at each 
gene region together with proportion of CpGs located at the island from each gene region in Supplementary 
Figure S1. It is shown that the proportion of age-methylated CpGs by gene region is closely correlated with the 
proportion of CpGs residing at CGI in the region (correlation coefficient 0.995) again indicating that the differ-
ential methylation pattern across gene regions is highly related to region-specific composition of CpGs at CGI, 
shore/shelf or open sea.
Pathway analysis. The 5,168 double-replicated CpGs in Supplementary Table S1 were grouped into 
age-methylated (2,028) and demethylated (3,140) CpGs which were annotated to 578 and 1,051 nearest genes 
respectively. The lists of linked genes were submitted to the GSEA website to look for canonical pathways in 
MSigDB over-represented by each gene list. Large numbers of pathways were identified from which the top 50 are 
presented in Supplementary Table S2 for age-methylated CpGs and Supplementary Table S3 for age-demethylated 
CpGs. It is interesting to see that, among the top 10 gene sets in the two tables, only 1 gene set overlaps, NABA 
matrisome. The top significant pathways in Supplementary Table S2 are dominated by cellular signalling activities 
involving, for example, G protein-coupled receptors (GPCRs) while in Supplementary Table S3 by gene activities 
mainly involving the extracellular matrix (ECM).
Discussion
Based on a relatively large collection of samples from older people and using a double replication strategy, we have 
identified 5,618 CpGs that changed their white blood cell methylation profiles in the aging cohorts with majority 
of them demethylated over increasing age. The significantly higher proportion of demethylation (60.76%) than 
methylation (39.24%) (p < 2.2e-16) among the double-replicated CpGs is not surprising as global decline in DNA 
methylation level of the methylome is the predominant event in aging9. The excessive pattern of demethylation 
over methylation with aging has also been reported as 64% by Johansson et al.10 using 421 individuals and as 54% 
by Marttila et al.4 using 143 individuals, with the former very close to our estimate.
Characterization of the double replicated CpGs by their distribution over gene regions was done first by exam-
ining the relative and absolute proportions of methylated and demethylated CpGs at each gene region. From the 
Tables 1 and 2 and Fig. 2, it is clear that there are excessive age-related gains in methylation at TSS200 and 1stExon 
and the rest of gene regions are characterized by loss of methylation. In the literature, it has been shown that 
increased methylation surrounding TSS is associated with gene inactivation11 and also methylation of the 1stExon 
is linked to gene silencing12. On the other hand, demethylation in the gene body is associated with suppression of 
gene expression13. Taking together, the differential distributions of both methylated and demethylated CpGs over 
gene region can all be related to the reduced gene activity during aging.
Our estimates of relative proportions (Tables 1 and 3, Figs 2a and 3a) revealed similar patterns of distribu-
tion of differentially methylated sites across gene regions as described by Marttila et al.4. The consistent find-
ings suggest that age-associated DNA methylations are differentially distributed over gene regions as compared 
with the total CpGs carried by the microarray used in the studies. The differential distribution of age-associated 
methylation and demethylation across gene regions (Tables 1 and 2, Fig. 2) and over locations to CpG island 
(Tables 3 and 4, Fig. 3) could implicate different biological functions. It is interesting to see that, our analysis 
revealed, indeed, different functional clusters or gene sets over-represented by genes linked to age-methylated 
and demethylated CpGs (see Supplementary Tables S2 and S3). In Supplementary Table S2, the top significant 
Figure 4. A 3-dimensional histogram showing the proportion of age-methylated CpGs at each combination of 
gene regions (intergenic region, TSS1500, TSS200, 5′UTR, 1stExon, gene body, 3′UTR) and locations to CpG 
island (from open sea or non-CGI to shore/shelf and to CGI). It is clearly shown that methylation level at each 
gene region is mainly driven by age-associated methylation (gain) at CGI.
www.nature.com/scientificreports/
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canonical pathways are nearly all related to signalling pathways such as GPCR (G-protein coupled-receptors) 
signalling widely involved in overall physiological functions and pathological processes as well as progression 
of Alzheimer’s disease14. Cell-cell signalling was also reported by Florath et al.3, Marttila et al.4 and Tan et al.5 in 
their top significant pathways regulated by age-associated increase in DNA methylation. Interestingly, in an early 
microarray study, Tan et al.15 compared genome-wide gene expression between grandparents and grandchildren 
in the CEPH Utah families and reported cell-cell signalling and cell communication pathways as the top-most 
significant pathways enriched by differentially expressed genes dominated by decreased expression pattern with 
aging. Given the high concentration of age-methylated CpGs at gene promotor region that silences gene activity, 
the finding in this study could provide epigenetic evidence on the significant age-associated impairment in cellu-
lar signalling transduction during the aging process.
Although demethylation is found more frequently than methylation in the aging methylome, functional anno-
tation of age-associated demethylation sites identified by Johansson et al.10 and Marttila et al.4 failed to show any 
significant enrichment for specific functional pathways. Based on the double replicated CpGs, our pathway anal-
ysis on genes linked to the significantly demethylated CpG sites identified a large number of gene-sets with the 
topmost ones unanimously involving genes encoding extracellular matrix (ECM) and ECM-associated proteins 
(see Supplementary Table S3). The ECM is a collection of molecules (sugars, proteins, etc.) that function not only 
as a scaffold but also as a place where signals affecting cell migration and differentiation originate. The ECM has 
been a central topic of discussion in aging studies16. It is associated with numerous age-related diseases and dys-
functions, most of them involving elasticity and strength of connective tissue, cartilage, bone, blood vessels, and 
skin17. In fact, the role of ECM goes beyond structural properties of tissue. For example, degradation of ECM in 
heart tissues could impact the heart’s electrical conduction system, a probable contributor to the increased preva-
lence of arrhythmias and similar issues with advancing age18. In this sense, the top significant pathways from both 
age-methylated and demethylated CpGs overlap in regard to cell signalling. This is further evidenced by the gene 
set NABA_MATRISOME which appears as top-most significant gene set in both Supplementary Tables S2 and S3.
Based on genome-wide DNA methylation data measured over ages, Horvath19 and Hannum et al.20 have 
selected multiple age predictive CpG sites for defining DNA methylation age (DNAm age). It is interesting that 
among the 71 CpGs in the list from Hannum et al.20 or the Hannum list, 54 (76.06%) are present in our 5,168 
double-replicated CpGs, while of the 353 CpGs in the list from Horvath19, only 32 (9.07%) overlapped. This 
large difference in the overlapping rates can be due to the fact that the Horvath list was developed from relatively 
younger samples (mean age 43 years) while the mean age of the samples from Hannum et al.20 was more than 
20 years older which is closer to the age ranges covered in our discovery and replication samples. This evidence 
further shows that our current study is featured by discovery, validation and characterization of DNA methylation 
patterns associated with the aging process in the older population.
Finally, we want to point out that, although high overlapping rates had been found in the replication analysis, 
the number of the double-replicated CpGs could have been considerably reduced by the relatively small sizes 
of the replication samples. Some of the truly significant CpGs from the discovery stage could have failed in the 
replication stage purely due to the fact that the latter did not have enough statistical power to confirm their signif-
icance. Under this situation, the double-replicated CpGs could have been biased towards CpGs with large effect 
sizes as indicated by the red spots in Fig. 1.
In conclusion, profiling of the aging methylome in combination with a double-replication strategy identi-
fied 5,168 significantly age-associated CpGs with majority of them being demethylated with increasing age. The 
detected CpGs are characterized by high concentration of gain in methylation at 1stExon and TSS200 and a 
dominant pattern of loss of methylation at other gene regions and by overwhelming age-associated methylation 
in CpG island and demethylation at shore/shelf and open sea. Biological pathway analysis showed that age-related 
increase in DNA methylation is especially involved in cellular signalling activities while age-dependent demethyl-
ation is particularly related to functions of the extracellular matrix, both provide clues to epigenetic remodelling 
behind the aging process and age-related diseases.
Methods
The discovery samples. The discovery analysis was based on samples collected from the Lothian Birth 
Cohorts (LBC) consisting of individuals born in 1921 and 1936 who resided in the Lothian region of Scotland 
at ages about 79 years (born 1921, 515 individuals) and 70 years (born 1936, 1,005 individuals), respectively21. A 
total of 2,460 whole blood samples were collected from the 1,520 participants during follow-up periods of about 
10 years for the 1921 birth cohort, and about 6 years for the 1936 birth cohort. After sample level quality control 
(QC) on DNA methylation data measured on whole blood using the Illumina Infinium Human DNA methylation 
450 K array, 2,195 samples from 1,366 individuals remained. DNA methylation measurements were available for 
485,512 CpG sites from the array. We removed sites on sex chromosomes leaving 473,864 autosomal CpGs for 
subsequent analysis. The LBC data have been deposited to the European Genome-phenome Archive (https://
www.ebi.ac.uk/ega/home) with accession number EGAS00001000910.
Ethics permission for the LBC1921 was obtained from the Lothian Research Ethics Committee (Wave 
1: LREC/1998/4/183). Ethics permission for the LBC1936 was obtained from the Multi-Center Research 
Ethics Committee for Scotland (Wave 1: MREC/01/0/56), the Lothian Research Ethics Committee (Wave 1: 
LREC/2003/2/29). Written informed consent was obtained from all subjects. The study was conducted in accord-
ance with the principles of the Helsinki Declaration.
The validation samples. The cross-sectional Danish twins. The cross-sectional sample for validation con-
sisted of 150 pairs of identical twins aged 30 to 74 years22. The sample can be divided into two age groups, i.e. a 
young group aged from 30–37 years (154 samples), and an old group aged 57–74 years (146 samples) with a gap of 
20 years between the two groups. DNA methylation was measured using the same array platform as in discovery 
www.nature.com/scientificreports/
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samples. Both raw and processed DNA methylation data for the cross-sectional samples have been deposited to 
the NCBI GEO database (http://www.ncbi.nlm.nih.gov/geo) under accession number GSE61496.
The study was approved by The Regional Scientific Ethical Committees for Southern Denmark (S-20090033) 
and conducted in accordance with the Helsinki II declaration. Informed consent was obtained from all subjects.
The longitudinal Danish twins. The longitudinal sample for validation included of 86 elderly Danish twins (18 
monozygotic or MZ pairs; 25 dizygotic or DZ pairs) collected by the Longitudinal Study of Aging Danish Twins 
(LSADT) initiated in 19955, 23. The project collected like-sex twin pairs born in Denmark for longitudinal assess-
ment of aging-related phenotypes. The participants were born before 1923 with age ranging from 73–82 years 
in 1997 when first blood samples were taken. The second blood samples were drawn in 2007 after a ten-year 
follow-up. Genome-wide DNA methylation was measured using the same platform as in the discovery samples 
(i.e. Illumina Infinium Human DNA methylation 450 K beadchip). The raw and processed DNA methylation 
data have been deposited to the NCBI GEO database http://www.ncbi.nlm.nih.gov/geo under accession number 
GSE73115.
The study was approved by the Danish Scientific Ethics Committees and conducted in accordance with the 
Helsinki II declaration. Informed consent was obtained from all subjects.
Estimating and adjusting cell composition. It has been shown that cell composition in the whole blood 
can change as a result of aging2 and it is thus critical to account for cellular heterogeneity in epigenetic studies 
of aging24. Based on the downloaded β-value for DNA methylation percentage for LBC, we estimated blood cell 
composition in each individual sample for 6 blood cell types: CD8T, CD4T, natural killer cell, B cell, monocyte, 
and granulocyte using the R package celltypes450 (https://github.com/brentp/celltypes450). The package esti-
mates cell-type composition in 450 K data using Houseman’s method25. Cell compositions for the Danish vali-
dation samples were estimated by applying the R package minfi (http://bioconductor.org/packages/release/bioc/
html/minfi.html) to measured signals derived from the green and red channels26.
Data analysis. The age-dependent DNA methylation patterns were analysed by fitting a regression model to 
each CpG site regressing methylation measurement on individual’s age at sampling. Before fitting the model, 
DNA methylation percentage, i.e. the β-value, was transformed into M-value using logit transformation to ensure 
normal or approximately normal distribution. Besides age, the regression model also included the estimated 
blood cell composition for adjustment. Considering that the LBC samples contained repeated measurements over 
follow-ups, statistical significance of age-dependent association of DNA methylation was assessed empirically 
using computer permutation that randomized age at observation to generate a null distribution of random p 
values. In our analysis, the computer permutation was combined with correction for multiple testing by estimat-
ing family-wise error rate (FWER). To do that, for every random EWAS performed on age permuted data, a 
minimum p value was recorded. A null distribution of minimum p values was created based on K (we used 
K = 300) random EWAS. FWER for each CpG was estimated as = ∑ <=FWER I
K
[Pvalue(perm)(i) Pvalue (obs)]i
K
1 .
The analyses of validation data were done by fitting mixed effect models as described in Tan et al.5. All statisti-
cal analyses were performed using the free R software (https://www.r-project.org) and related packages.
Pathway analysis. The identified significant CpGs (FWER<0.05) were annotated to nearest genes and eval-
uated for over-representation of gene-sets or pathways in the Molecular Signatures Database (MSigDB). The 
over-representation analysis compares a reference set of genes to a test gene-set using the hypergeometric test. 
The probability of finding X > k significant genes in a particular gene-set or pathway can be calculated using the 
hypergeometric distribution, i.e. > = − ∑ −−= ( ) ( )( )p X k mr N mn r Nn( ) 1 /rk 0 , where N is the number of genes 
annotated to CpGs on the 450 K array, m is the number of genes annotated to the significant CpGs, n is the num-
ber of genes in the particular gene-set or pathway, and k is the number of genes that are both linked to significant 
CpGs and present in the particular gene-set or pathway. The analysis was performed using the analytical tool 
provided by Gene-Set Enrichment Analysis (GSEA) (http://www.broadinstitute.org/gsea/index.jsp).
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